サマリー

世界のHIV治療薬市場 2023-2027
HIV治療薬市場は、2022-2027年に1億4,477.51億米ドルの成長が予測され、予測期間中のCAGRは5.46%で加速すると予測されています。この調査レポートは、HIV治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、世界的なHIVエイズの有病率の増加、関連リスク因子の症例の増加、老年人口の急増によって牽引されています。
Technavio社のHIV治療薬市場は以下のように区分されます：
流通チャネル別
- オフライン
- オンライン
治療法別
- 併用HIV治療薬
- インテグラーゼ阻害薬
- 非ヌクレオシド系逆転写酵素阻害薬
- その他
地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、HIV治療へのアクセスの拡大が、今後数年間のHIV治療薬市場の成長を促進する主な要因の1つであるとしている。また、標的治療薬に対する需要の高まりとHIVウイルスの診断法の進歩は、市場の大きな需要につながると考えられます。
本レポートでは、HIV治療薬市場について以下の領域をカバーしています：
- HIV治療薬市場の規模
- HIV治療薬市場予測
- HIV治療薬市場の産業分析
堅牢なベンダー分析は、クライアントが市場での地位を向上させるために設計されており、これに沿って、本レポートでは、AbbVie社、Aspen Pharmacare Holdings Ltd、Aurobindo Pharma Ltd.を含むいくつかの主要なHIV薬市場ベンダーの詳細な分析を提供しています、ベーリンガー・インゲルハイム・インターナショナルGmbH、ブリストル・マイヤーズ・スクイブCo.、シプラLtd.、エムキュア・ファーマシューティカルズLtd.、ギリアド・サイエンシズInc.、グラクソ・スミスクラインPlc.、ヘテロ・ラボLtd.、ジョンソン・アンド・ジョンソン・サービスInc.、ルパンLtd.、マクレオッズ・ファーマシューティカルズLtd.、メルク・アンド・カンパニーInc.、ストリデス・ファーマ・サイエンスInc.Ltd.、Strides Pharma Science Ltd.、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、Torrent Pharmaceuticals Ltd.、Viatris Inc.、Cadila Pharmaceuticals Ltd.などである。また、HIV治療薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、以下をご覧ください - [https://www.technavio.com/report/HIV-drugs-market-analysis](https://www.technavio.com/report/hiv-drugs-market-analysis)
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Therapy
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global HIV drugs market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global hiv drugs market 2017 - 2021 ($ million)
o 4.2 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
o 4.3 Therapy Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Offline - Market size and forecast 2022-2027
o Exhibit 34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Offline - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
o 6.4 Online - Market size and forecast 2022-2027
o Exhibit 38: Chart on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Online - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Online - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Distribution Channel
o Exhibit 42: Market opportunity by Distribution Channel ($ million)
o Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Therapy
o 7.1 Market segments
o Exhibit 44: Chart on Therapy - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Therapy - Market share 2022-2027 (%)
o 7.2 Comparison by Therapy
o Exhibit 46: Chart on Comparison by Therapy
o Exhibit 47: Data Table on Comparison by Therapy
o 7.3 Combination HIV medicines - Market size and forecast 2022-2027
o Exhibit 48: Chart on Combination HIV medicines - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Combination HIV medicines - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Combination HIV medicines - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Combination HIV medicines - Year-over-year growth 2022-2027 (%)
o 7.4 Integrase inhibitors - Market size and forecast 2022-2027
o Exhibit 52: Chart on Integrase inhibitors - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Integrase inhibitors - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Integrase inhibitors - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Integrase inhibitors - Year-over-year growth 2022-2027 (%)
o 7.5 Non-nucleoside reverse transcriptase inhibitors - Market size and forecast 2022-2027
o Exhibit 56: Chart on Non-nucleoside reverse transcriptase inhibitors - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Non-nucleoside reverse transcriptase inhibitors - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Non-nucleoside reverse transcriptase inhibitors - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Non-nucleoside reverse transcriptase inhibitors - Year-over-year growth 2022-2027 (%)
o 7.6 Others - Market size and forecast 2022-2027
o Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Therapy
o Exhibit 64: Market opportunity by Therapy ($ million)
o Exhibit 65: Data Table on Market opportunity by Therapy ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 China - Market size and forecast 2022-2027
o Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.10 UK - Market size and forecast 2022-2027
o Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.11 Canada - Market size and forecast 2022-2027
o Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 115: AbbVie Inc. - Overview
o Exhibit 116: AbbVie Inc. - Product / Service
o Exhibit 117: AbbVie Inc. - Key news
o Exhibit 118: AbbVie Inc. - Key offerings
o 12.4 Aurobindo Pharma Ltd.
o Exhibit 119: Aurobindo Pharma Ltd. - Overview
o Exhibit 120: Aurobindo Pharma Ltd. - Product / Service
o Exhibit 121: Aurobindo Pharma Ltd. - Key offerings
o 12.5 Bristol Myers Squibb Co.
o Exhibit 122: Bristol Myers Squibb Co. - Overview
o Exhibit 123: Bristol Myers Squibb Co. - Product / Service
o Exhibit 124: Bristol Myers Squibb Co. - Key news
o Exhibit 125: Bristol Myers Squibb Co. - Key offerings
o 12.6 Cadila Pharmaceuticals Ltd.
o Exhibit 126: Cadila Pharmaceuticals Ltd. - Overview
o Exhibit 127: Cadila Pharmaceuticals Ltd. - Product / Service
o Exhibit 128: Cadila Pharmaceuticals Ltd. - Key offerings
o 12.7 Cipla Ltd.
o Exhibit 129: Cipla Ltd. - Overview
o Exhibit 130: Cipla Ltd. - Business segments
o Exhibit 131: Cipla Ltd. - Key news
o Exhibit 132: Cipla Ltd. - Key offerings
o Exhibit 133: Cipla Ltd. - Segment focus
o 12.8 Emcure Pharmaceuticals Ltd.
o Exhibit 134: Emcure Pharmaceuticals Ltd. - Overview
o Exhibit 135: Emcure Pharmaceuticals Ltd. - Product / Service
o Exhibit 136: Emcure Pharmaceuticals Ltd. - Key offerings
o 12.9 Gilead Sciences Inc.
o Exhibit 137: Gilead Sciences Inc. - Overview
o Exhibit 138: Gilead Sciences Inc. - Product / Service
o Exhibit 139: Gilead Sciences Inc. - Key news
o Exhibit 140: Gilead Sciences Inc. - Key offerings
o 12.10 GlaxoSmithKline Plc
o Exhibit 141: GlaxoSmithKline Plc - Overview
o Exhibit 142: GlaxoSmithKline Plc - Business segments
o Exhibit 143: GlaxoSmithKline Plc - Key news
o Exhibit 144: GlaxoSmithKline Plc - Key offerings
o Exhibit 145: GlaxoSmithKline Plc - Segment focus
o 12.11 Hetero Labs Ltd.
o Exhibit 146: Hetero Labs Ltd. - Overview
o Exhibit 147: Hetero Labs Ltd. - Product / Service
o Exhibit 148: Hetero Labs Ltd. - Key offerings
o 12.12 Johnson and Johnson Services Inc.
o Exhibit 149: Johnson and Johnson Services Inc. - Overview
o Exhibit 150: Johnson and Johnson Services Inc. - Business segments
o Exhibit 151: Johnson and Johnson Services Inc. - Key news
o Exhibit 152: Johnson and Johnson Services Inc. - Key offerings
o Exhibit 153: Johnson and Johnson Services Inc. - Segment focus
o 12.13 Lupin Ltd.
o Exhibit 154: Lupin Ltd. - Overview
o Exhibit 155: Lupin Ltd. - Product / Service
o Exhibit 156: Lupin Ltd. - Key news
o Exhibit 157: Lupin Ltd. - Key offerings
o 12.14 Merck and Co. Inc.
o Exhibit 158: Merck and Co. Inc. - Overview
o Exhibit 159: Merck and Co. Inc. - Business segments
o Exhibit 160: Merck and Co. Inc. - Key news
o Exhibit 161: Merck and Co. Inc. - Key offerings
o Exhibit 162: Merck and Co. Inc. - Segment focus
o 12.15 Sun Pharmaceutical Industries Ltd.
o Exhibit 163: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 164: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 165: Sun Pharmaceutical Industries Ltd. - Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 166: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 167: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 168: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 169: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 170: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.17 Viatris Inc.
o Exhibit 171: Viatris Inc. - Overview
o Exhibit 172: Viatris Inc. - Business segments
o Exhibit 173: Viatris Inc. - Key news
o Exhibit 174: Viatris Inc. - Key offerings
o Exhibit 175: Viatris Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 176: Inclusions checklist
o Exhibit 177: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 178: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 179: Research methodology
o Exhibit 180: Validation techniques employed for market sizing
o Exhibit 181: Information sources
o 13.5 List of abbreviations
o Exhibit 182: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global hiv drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Distribution Channel ($ million)
Exhibits43: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits44: Chart on Therapy - Market share 2022-2027 (%)
Exhibits45: Data Table on Therapy - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Therapy
Exhibits47: Data Table on Comparison by Therapy
Exhibits48: Chart on Combination HIV medicines - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Combination HIV medicines - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Combination HIV medicines - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Combination HIV medicines - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Integrase inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Integrase inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Integrase inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Integrase inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Non-nucleoside reverse transcriptase inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Non-nucleoside reverse transcriptase inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Non-nucleoside reverse transcriptase inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Non-nucleoside reverse transcriptase inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Therapy ($ million)
Exhibits65: Data Table on Market opportunity by Therapy ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: AbbVie Inc. - Overview
Exhibits116: AbbVie Inc. - Product / Service
Exhibits117: AbbVie Inc. - Key news
Exhibits118: AbbVie Inc. - Key offerings
Exhibits119: Aurobindo Pharma Ltd. - Overview
Exhibits120: Aurobindo Pharma Ltd. - Product / Service
Exhibits121: Aurobindo Pharma Ltd. - Key offerings
Exhibits122: Bristol Myers Squibb Co. - Overview
Exhibits123: Bristol Myers Squibb Co. - Product / Service
Exhibits124: Bristol Myers Squibb Co. - Key news
Exhibits125: Bristol Myers Squibb Co. - Key offerings
Exhibits126: Cadila Pharmaceuticals Ltd. - Overview
Exhibits127: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits128: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits129: Cipla Ltd. - Overview
Exhibits130: Cipla Ltd. - Business segments
Exhibits131: Cipla Ltd. - Key news
Exhibits132: Cipla Ltd. - Key offerings
Exhibits133: Cipla Ltd. - Segment focus
Exhibits134: Emcure Pharmaceuticals Ltd. - Overview
Exhibits135: Emcure Pharmaceuticals Ltd. - Product / Service
Exhibits136: Emcure Pharmaceuticals Ltd. - Key offerings
Exhibits137: Gilead Sciences Inc. - Overview
Exhibits138: Gilead Sciences Inc. - Product / Service
Exhibits139: Gilead Sciences Inc. - Key news
Exhibits140: Gilead Sciences Inc. - Key offerings
Exhibits141: GlaxoSmithKline Plc - Overview
Exhibits142: GlaxoSmithKline Plc - Business segments
Exhibits143: GlaxoSmithKline Plc - Key news
Exhibits144: GlaxoSmithKline Plc - Key offerings
Exhibits145: GlaxoSmithKline Plc - Segment focus
Exhibits146: Hetero Labs Ltd. - Overview
Exhibits147: Hetero Labs Ltd. - Product / Service
Exhibits148: Hetero Labs Ltd. - Key offerings
Exhibits149: Johnson and Johnson Services Inc. - Overview
Exhibits150: Johnson and Johnson Services Inc. - Business segments
Exhibits151: Johnson and Johnson Services Inc. - Key news
Exhibits152: Johnson and Johnson Services Inc. - Key offerings
Exhibits153: Johnson and Johnson Services Inc. - Segment focus
Exhibits154: Lupin Ltd. - Overview
Exhibits155: Lupin Ltd. - Product / Service
Exhibits156: Lupin Ltd. - Key news
Exhibits157: Lupin Ltd. - Key offerings
Exhibits158: Merck and Co. Inc. - Overview
Exhibits159: Merck and Co. Inc. - Business segments
Exhibits160: Merck and Co. Inc. - Key news
Exhibits161: Merck and Co. Inc. - Key offerings
Exhibits162: Merck and Co. Inc. - Segment focus
Exhibits163: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits164: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits165: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits166: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits167: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits168: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits169: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits170: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits171: Viatris Inc. - Overview
Exhibits172: Viatris Inc. - Business segments
Exhibits173: Viatris Inc. - Key news
Exhibits174: Viatris Inc. - Key offerings
Exhibits175: Viatris Inc. - Segment focus
Exhibits176: Inclusions checklist
Exhibits177: Exclusions checklist
Exhibits178: Currency conversion rates for US$
Exhibits179: Research methodology
Exhibits180: Validation techniques employed for market sizing
Exhibits181: Information sources
Exhibits182: List of abbreviations